Idenix Pharmaceuticals (IDIX)

[gofishmarko]

NM283 = ...

NoMás 283 ???

The next question to consider is : " What price would IDIX shareholders accept from NVS in an acquisition offer ? "

I'm guessing NVS will wait a while before making such an offer -- maybe until after AASLD , where IDIX will have one last chance to convince investors of IDIX' value as an antiviral drug discovery engine.

Then , NVS will offer to buy the balance of IDIX at a premium of 10-15 % to the then-current SP. Large shareholders will protest the lowball takeover attempt , of course , and NVS will then come back with an offer at a 30% premium , or thereabouts , which will be accepted by the BOD and shareholders. This is in line with what happened in the NVS purchase of Chiron.

For those who can time the buy-sell to capture that 30% premium , it will be a great investment. For most of us here , so far at least , not so great.